BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 35689852)

  • 21. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.
    Li JY; Zhao Y; Gong S; Wang MM; Liu X; He QM; Li YQ; Huang SY; Qiao H; Tan XR; Ye ML; Zhu XH; He SW; Li Q; Liang YL; Chen KL; Huang SW; Li QJ; Ma J; Liu N
    Nat Commun; 2023 Feb; 14(1):865. PubMed ID: 36797289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
    Mao YP; Wang SX; Gao TS; Zhang N; Liang XY; Xie FY; Zhang Y; Zhou GQ; Guo R; Luo WJ; Li YJ; Liang SQ; Lin L; Li WF; Liu X; Xu C; Chen YP; Lv JW; Huang SH; Liu LZ; Li JB; Tang LL; Chen L; Sun Y; Ma J
    BMJ; 2023 Feb; 380():e072133. PubMed ID: 36746459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Wang X; Li W; Lou N; Han W; Hai B; Xiao W; Zhang X
    Pharmgenomics Pers Med; 2023; 16():1-14. PubMed ID: 36636625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
    Wang YQ; Wu DH; Wei D; Shen JY; Huang ZW; Liang XY; Cho WCS; Ma J; Lv J; Chen YP
    Sci Adv; 2023 Jan; 9(1):eadd0960. PubMed ID: 36608137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABA regulates IL-1β production in macrophages.
    Fu J; Han Z; Wu Z; Xia Y; Yang G; Yin Y; Ren W
    Cell Rep; 2022 Dec; 41(10):111770. PubMed ID: 36476877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N
    Zhao Y; Huang S; Tan X; Long L; He Q; Liang X; Bai J; Li Q; Lin J; Li Y; Liu N; Ma J; Chen Y
    Adv Sci (Weinh); 2022 Dec; 9(36):e2205091. PubMed ID: 36310139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
    Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
    Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial data of Anti-PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A review.
    Adkins DR; Haddad RI
    Cancer Treat Rev; 2022 Sep; 109():102428. PubMed ID: 35753157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.
    Hu YJ; Lu TZ; Guo QJ; Zhang L; Xiao YP; Lin SJ; Zhou H; Zheng DC; Ding SR; Liu LZ; Gong XC; Li JG; Pan JJ; Xia YF
    Radiother Oncol; 2023 Jan; 178():109436. PubMed ID: 36464180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
    Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
    J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DUSP2 deletion with CRISPR/Cas9 promotes Mauthner cell axonal regeneration at the early stage of zebrafish.
    Shao GJ; Wang XL; Wei ML; Ren DL; Hu B
    Neural Regen Res; 2023 Mar; 18(3):577-581. PubMed ID: 36018180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DUSP2-mediated inhibition of tubular epithelial cell pyroptosis confers nephroprotection in acute kidney injury.
    Xiong J; Ran L; Zhu Y; Wang Y; Wang S; Wang Y; Lan Q; Han W; Liu Y; Huang Y; He T; Li Y; Liu L; Zhao J; Yang K
    Theranostics; 2022; 12(11):5069-5085. PubMed ID: 35836796
    [No Abstract]   [Full Text] [Related]  

  • 33. Stable knockdown of Drp1 improves retinoic acid-BDNF-induced neuronal differentiation through global transcriptomic changes and results in reduced phosphorylation of ERK1/2 independently of DUSP1 and 6.
    Ghani M; Zohar P; Ujlaki G; Tóth M; Amsalu H; Póliska S; Tar K
    Front Cell Dev Biol; 2024; 12():1342741. PubMed ID: 38550381
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer.
    Ren D; Li W; Zeng R; Liu X; Liang H; Xiong W; Yang C; Jin X
    Cell Death Differ; 2024 May; 31(5):592-604. PubMed ID: 38514847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic regulation in cancer.
    Gu M; Ren B; Fang Y; Ren J; Liu X; Wang X; Zhou F; Xiao R; Luo X; You L; Zhao Y
    MedComm (2020); 2024 Feb; 5(2):e495. PubMed ID: 38374872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.
    Fang XL; Li QJ; Lin JY; Huang CL; Huang SY; Tan XR; He SW; Zhu XH; Li JY; Gong S; Qiao H; Li YQ; Liu N; Ma J; Zhao Y; Tang LL
    Cell Death Dis; 2024 Feb; 15(2):112. PubMed ID: 38321024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A glimpse into novel acylations and their emerging role in regulating cancer metastasis.
    Shi H; Cui W; Qin Y; Chen L; Yu T; Lv J
    Cell Mol Life Sci; 2024 Feb; 81(1):76. PubMed ID: 38315203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer.
    He Y; Ma Y; Zhu Y; Zhang J; Zhao S; Zhang D; Xu D; Li Y; Tong Z; Zhao W
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.
    Yu X; Zhao P; Luo Q; Wu X; Wang Y; Nan Y; Liu S; Gao W; Li B; Liu Z; Cui Z
    Oncogene; 2024 Feb; 43(6):420-433. PubMed ID: 38092960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma.
    Wang H; Liu Z; Du Y; Cheng X; Gao S; Gao Y; Shang P
    Front Oncol; 2023; 13():1210910. PubMed ID: 38074636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.